M07.65
Enteropathic arthropathies, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Enteropathic arthropathy of the hip, classified under ICD-10 code M07.65, is a form of joint inflammation associated with underlying gastrointestinal conditions, particularly inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. This condition involves inflammation and damage to the hip joint, leading to pain, stiffness, and decreased mobility. It is part of a broader category of enteropathic arthropathies, which are joint disorders linked to intestinal diseases. Recognizing this condition is vital for appropriate management aimed at controlling both gastrointestinal symptoms and joint inflammation.
Causes & Symptoms
Clinical Causes: Chronic inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis) Genetic predispositions affecting immune regulation Environmental factors contributing to immune system response Altered gut microbiota influencing systemic inflammation Potential genetic susceptibility that increases risk for joint involvement
Key Symptoms: Hip joint pain, often dull or aching Stiffness and reduced range of motion in the hip Swelling or tenderness around the hip joint Pain that worsens with activity or prolonged immobility Possible decrease in Hip strength and stability In some cases, systemic symptoms of gastrointestinal disease, such as diarrhea, abdominal pain, and fatigue
Diagnostic & Treatment
Diagnosis Path: Medical history review emphasizing gastrointestinal and joint symptoms Physical examination focusing on the hips and observing joint tenderness, swelling, and range of motion Imaging studies such as X-rays, MRI, or ultrasound to evaluate joint inflammation and damage Blood tests to identify inflammation markers (e.g., ESR, CRP) Laboratory tests for gastrointestinal disease activity (e.g., stool tests, endoscopy results) Exclusion of other causes of arthritis like rheumatoid arthritis or osteoarthritis
Treatment Protocols: Medications to control inflammation and immune response, such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or disease-modifying antirheumatic drugs (DMARDs) Biologic therapies aimed at specific immune pathways involved in inflammatory bowel and joint disease Physical therapy to improve joint mobility and strengthen surrounding muscles Lifestyle modifications including weight management and activity adjustments Management of the underlying gastrointestinal condition to reduce systemic inflammatory response In severe cases, surgical intervention like hip replacement may be considered when joint damage is significant
Clinical Advice & FAQs
Billing Guidance
Is M07.65 a billable ICD-10 code?
Yes, M07.65 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M07.65?
Clinical documentation must specify the nature of Enteropathic arthropathies, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
